T ScientificLtd Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

SangWoo Kim

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	0.1%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Is T ScientificLtd (KOSDAQ:057680) A Risky Investment?

Oct 02

Geschäftsführer

SangWoo Kim

no data

Amtszeit

SangWoo Kim serves as Chief Executive Officer of T Scientific Co.,Ltd.

T ScientificLtd Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Less than half of directors are independent

Less than half of directors are independent

T Scientific Co., Ltd., Annual General Meeting, Mar 24, 2021

Recent updates

Is T ScientificLtd (KOSDAQ:057680) A Risky Investment?

New minor risk - Share price stability

New major risk - Financial position

T Scientific Co.,Ltd. announced that it has received KRW 2.99999997 billion in funding from WIZIT Co., Ltd.

T Scientific Co.,Ltd. announced that it expects to receive KRW 2.99999997 billion in funding from WIZIT Co., Ltd.

Full year 2023 earnings released: ₩737 loss per share (vs ₩210 loss in FY 2022)

T Scientific Co.,Ltd. announced that it has received KRW 5 billion in funding from FSN Co., Ltd.

T Scientific Co.,Ltd. announced that it expects to receive KRW 5 billion in funding from FSN Co., Ltd.

New minor risk - Market cap size

New minor risk - Share price stability

Less than half of directors are independent

T Scientific Co.,Ltd announced that it has received KRW 16 billion in funding from Daiduck Piping Co., Ltd.

T Scientific Co.,Ltd announced that it expects to receive KRW 4.99999914 billion in funding from WIZIT Co., Ltd.

Less than half of directors are independent

T Scientific Co.,Ltd announced that it has received KRW 30 billion in funding

T Scientific Co., Ltd., Annual General Meeting, Mar 24, 2021

T Scientific Co.,Ltd announced that it has received KRW 10 billion in funding from Swanicoco Co., Ltd.

T Scientific Co.,Ltd announced that it expects to receive KRW 10 billion in funding from Swanicoco Co., Ltd. and other investors

New 90-day low: ₩2,980

New 90-day low: ₩4,180

T Scientific Co.,Ltd (KOSDAQ:A057680) agreed to acquire additional 4.5% stake in TMD Lab for KRW 1.4 billion.

T Scientific Co.,Ltd announced that it has received KRW 5.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm

New 90-day high - ₩5,200

T Scientific Co.,Ltd announced that it expects to receive KRW 5.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm

Geschäftsführer

Amtszeit